Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Review article: The long-term management of ulcerative colitis
S. B. Hanauer
*
*
Corresponding author for this work
Medicine, Gastroenterology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Review article: The long-term management of ulcerative colitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Remission
100%
Ulcerative Colitis
100%
Long-term Management
100%
Maintenance Therapy
60%
Aminosalicylates
40%
Acute Therapy
40%
Treatment Regimen
20%
Smoking Cessation
20%
Clinical Remission
20%
Bleeding
20%
Patient Adherence
20%
Clinical Symptoms
20%
Duration of Therapy
20%
Granularity
20%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
20%
Controlled Experiment
20%
Mucosa
20%
Disease Risk
20%
Diarrhea
20%
Potential Risk
20%
Long-term Complications
20%
Endoscopy
20%
Immunomodulation
20%
Disease Activity
20%
Remission Induction
20%
Relapse Risk
20%
Topical Therapy
20%
Relapse Prevention
20%
Ulcer
20%
Mesalamine
20%
Reduced Frequency
20%
Mesalazine
20%
Distal Colitis
20%
Mercaptopurine
20%
Ciclosporin
20%
Optimal Maintenance
20%
Induction Regimen
20%
Inflammatory Symptoms
20%
Friability
20%
Medicine and Dentistry
Ulcerative Colitis
100%
Maintenance Therapy
100%
Mesalazine
66%
Treatment Duration
33%
Topical Treatment
33%
Disease Activity
33%
Cyclosporine
33%
Patient Compliance
33%
Diarrhea
33%
Colitis
33%
Rectal Bleeding
33%
Controlled Clinical Trial
33%
Nonsteroid Antiinflammatory Agent
33%
Mucosa
33%
Endoscopy
33%
Azathioprine
33%
Friability
33%
Immunomodulation
33%
Ulcer
33%
Mercaptopurine
33%
Nursing and Health Professions
Remission
100%
Ulcerative Colitis
100%
Maintenance Therapy
42%
Aminosalicylic Acid
28%
Mesalazine
28%
Ulcer
14%
Rectum Hemorrhage
14%
Patient Compliance
14%
Disease Activity
14%
Diarrhea
14%
Treatment Duration
14%
Colitis
14%
Nonsteroid Antiinflammatory Agent
14%
Topical Treatment
14%
Ciclosporin
14%
Endoscopy
14%
Mercaptopurine
14%
Azathioprine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Ulcerative Colitis
100%
Aminosalicylic Acid
28%
Controlled Clinical Trial
14%
Immunomodulation
14%
Ciclosporin
14%
Non-Steroidal Anti-Inflammatory Drug
14%
Disease Activity
14%
Ulcer
14%
Diarrhea
14%
Colitis
14%
Azathioprine
14%
Rectum Hemorrhage
14%
Mercaptopurine
14%